BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 04, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

NBI-98854: Phase I data

Preliminary data from the single ascending-dose, Canadian Phase I trial in healthy volunteers showed that NBI-98854 was safe...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >